Isovaleramide NEW
| Price | $55 |
| Package | 500mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-11 |
Product Details
| Product Name: Isovaleramide | CAS No.: 541-46-8 |
| Purity: 99.47% | Supply Ability: 10g |
| Release date: 2026/05/11 |
Product Introduction
Bioactivity
| Name | Isovaleramide |
| Description | Isovaleramide (3-Methylbutanamide) is an anticonvulsant molecule isolated from Valeriana pavonii, which can inhibit the liver alcohol dehydrogenases. |
| In vitro | Research on the reproductive toxicity of Isovaleramide in mice, rats, and rabbits demonstrates its potential to be significantly lower than that of VPA. Oral administration of Isovaleramide at a dose of 100 mg/kg resulted in a 90% protection index against maximal electroshock seizures in mice. |
| In vivo | At a concentration of 0.15%, Isovaleramide induces the formation of nitrile hydratase in Rhodococcus sp. YH 3-3. In in vitro assays, 300 μM Isovaleramide inhibits 42% of 3H-FNZ binding to its target site. At concentrations up to 1000 μM, Isovaleramide does not affect the binding and uptake assays of various neurotransmitters in vitro, suggesting that its mechanism of action does not involve direct receptor-mediated effects. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (19.77 mM), Sonication is recommended. Ethanol : 16 mg/mL (158.18 mM), Sonication is recommended. H2O : < 1 mg/mL (insoluble or slightly soluble) DMSO : 75 mg/mL (741.47 mM), Sonication is recommended. |
| Keywords | Isovaleramide | Inhibitor | inhibit | Alcohol DHO |
| Inhibitors Related | Mycophenolate Mofetil | p-Hydroxybenzaldehyde | Urethane | Benzyl alcohol | 2-Methylaminoethanol | Methotrexate disodium | Penicillin G sodium salt | Valproic Acid | Dimethyl malonate | Methyl eugenol | Dihydromyricetin | Methionine |
| Related Compound Libraries | Anti-Tumor Natural Product Library | Bioactive Compound Library | Anti-Cancer Metabolism Compound Library | Natural Product Library | Drug Repurposing Compound Library | Tobacco Monomer Library | NO PAINS Compound Library | Natural Product Library for HTS | Metabolism Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Anti-Metabolism Disease Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
![6-Amino-9-[2-deoxy-β-D-ribofuranosyl]-9H-purine](https://img.chemicalbook.com/ProductImageEN1/2025-08/Large/9d2a56c6-6196-4fa0-bb3e-ffa828b85e09.png)
CAS:148171-35-1
-
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2026-02-02 | ||
| $55.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | |
| $92.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-04-30 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY